Nichols & Pratt Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11M | Sell |
141,131
-15,285
| -10% | -$1.23M | 0.67% | 32 |
|
|
2026
Q1 | $13.6M | Sell |
156,416
-1,732
| -1% | -$166K | 0.87% | 31 |
|
|
2025
Q4 | $15.2M | Buy |
158,148
+270
| +0.2% | +$26.2K | 0.95% | 30 |
|
|
2025
Q3 | $15M | Buy |
157,878
+109
| +0.1% | +$10K | 0.95% | 28 |
|
|
2025
Q2 | $13.8M | Buy |
157,769
+1,383
| +0.9% | +$117K | 0.92% | 30 |
|
|
2025
Q1 | $14M | Sell |
156,386
-4,776
| -3% | -$427K | 0.96% | 30 |
|
|
2024
Q4 | $12.9M | Buy |
161,162
+2,765
| +2% | +$239K | 0.86% | 31 |
|
|
2024
Q3 | $14.3M | Sell |
158,397
-6,890
| -4% | -$580K | 0.92% | 30 |
|
|
2024
Q2 | $13M | Buy |
165,287
+25
| +0% | +$2.05K | 0.88% | 30 |
|
|
2024
Q1 | $14.4M | Sell |
165,262
-1,349
| -0.8% | -$115K | 0.97% | 30 |
|
|
2023
Q4 | $13.7M | Sell |
166,611
-240
| -0.1% | -$18.3K | 0.98% | 29 |
|
|
2023
Q3 | $13M | Buy |
166,851
+205
| +0.1% | +$17.2K | 0.99% | 31 |
|
|
2023
Q2 | $14.7M | Buy |
166,646
+21,950
| +15% | +$1.89M | 1.07% | 30 |
|
|
2023
Q1 | $11.6M | Buy |
144,696
+8,420
| +6% | +$686K | 0.89% | 30 |
|
|
2022
Q4 | $10.6M | Buy |
136,276
+1,814
| +1% | +$147K | 0.85% | 32 |
|
|
2022
Q3 | $10.9M | Buy |
134,462
+130
| +0.1% | +$11.7K | 0.96% | 30 |
|
|
2022
Q2 | $12.1M | Buy |
134,332
+855
| +0.6% | +$86.6K | 0.99% | 30 |
|
|
2022
Q1 | $14.8M | Buy |
133,477
+2,175
| +2% | +$230K | 1.07% | 29 |
|
|
2021
Q4 | $13.6M | Buy |
131,302
+1,060
| +0.8% | +$123K | 0.94% | 34 |
|
|
2021
Q3 | $16.5M | Buy |
130,242
+250
| +0.2% | +$32.4K | 1.25% | 28 |
|
|
2021
Q2 | $16.1M | Buy |
129,992
+1,300
| +1% | +$163K | 1.22% | 29 |
|
|
2021
Q1 | $15.2M | Buy |
128,692
+1,120
| +0.9% | +$131K | 1.18% | 29 |
|
|
2020
Q4 | $14.9M | Buy |
127,572
+3,515
| +3% | +$387K | 1.18% | 32 |
|
|
2020
Q3 | $12.9M | Buy |
124,057
+8,347
| +7% | +$838K | 1.11% | 31 |
|
|
2020
Q2 | $10.6M | Buy |
115,710
+1,360
| +1% | +$130K | 0.95% | 37 |
|
|
2020
Q1 | $10.2M | Buy |
114,350
+2,075
| +2% | +$221K | 1.02% | 36 |
|
|
2019
Q4 | $12.7M | Sell |
112,275
-7,264
| -6% | -$797K | 1.05% | 35 |
|
|
2019
Q3 | $13M | Buy |
119,539
+1,280
| +1% | +$134K | 1.06% | 34 |
|
|
2019
Q2 | $11.5M | Buy |
118,259
+4,157
| +4% | +$380K | 0.95% | 35 |
|
|
2019
Q1 | $10.4M | Buy |
114,102
+6,620
| +6% | +$593K | 0.87% | 38 |
|
|
2018
Q4 | $9.71M | Sell |
107,482
-890
| -0.8% | -$83.2K | 0.91% | 37 |
|
|
2018
Q3 | $10.7M | Buy |
108,372
+1,811
| +2% | +$167K | 0.89% | 40 |
|
|
2018
Q2 | $9.12M | Buy |
106,561
+906
| +0.9% | +$75.7K | 0.82% | 40 |
|
|
2018
Q1 | $8.41M | Buy |
105,655
+5,835
| +6% | +$481K | 0.77% | 40 |
|
|
2017
Q4 | $8.09M | Buy |
99,820
+129
| +0.1% | +$10.3K | 0.7% | 41 |
|
|
2017
Q3 | $7.76M | Buy |
99,691
+3,615
| +4% | +$300K | 0.69% | 41 |
|
|
2017
Q2 | $8.53M | Buy |
96,076
+315
| +0.3% | +$26.6K | 0.78% | 40 |
|
|
2017
Q1 | $7.72M | Sell |
95,761
-40
| -0% | -$3.13K | 0.71% | 40 |
|
|
2016
Q4 | $6.81M | Buy |
95,801
+135
| +0.1% | +$10.6K | 0.64% | 40 |
|
|
2016
Q3 | $8.27M | Buy |
95,666
+225
| +0.2% | +$19.6K | 0.76% | 39 |
|
|
2016
Q2 | $8.29M | Buy |
95,441
+280
| +0.3% | +$22.6K | 0.75% | 40 |
|
|
2016
Q1 | $7.14M | Buy |
95,161
+210
| +0.2% | +$15.8K | 0.66% | 43 |
|
|
2015
Q4 | $7.3M | Sell |
94,951
-1,774
| -2% | -$134K | 0.7% | 41 |
|
|
2015
Q3 | $6.5M | Sell |
96,725
-549
| -0.6% | -$40.4K | 0.65% | 44 |
|
|
2015
Q2 | $7.21M | Buy |
97,274
+3,860
| +4% | +$295K | 0.67% | 41 |
|
|
2015
Q1 | $7.29M | Buy |
93,414
+1,145
| +1% | +$86.8K | 0.66% | 38 |
|
|
2014
Q4 | $6.66M | Buy |
92,269
+2,245
| +2% | +$156K | 0.59% | 41 |
|
|
2014
Q3 | $5.59M | Sell |
90,024
-6,550
| -7% | -$416K | 0.5% | 44 |
|
|
2014
Q2 | $6.16M | Sell |
96,574
-3,041
| -3% | -$185K | 0.53% | 42 |
|
|
2014
Q1 | $6.13M | Sell |
99,615
-1,650
| -2% | -$96.1K | 0.56% | 43 |
|
|
2013
Q4 | $5.81M | Buy |
101,265
+1,025
| +1% | +$58.1K | 0.55% | 41 |
|
|
2013
Q3 | $5.34M | Buy |
100,240
+65
| +0.1% | +$3.5K | 0.54% | 42 |
|
|
2013
Q2 | $5.17M | Buy |
+100,175
| New | +$4.95M | 0.54% | 42 |
|
Other funds holding MDT
Nichols & Pratt Advisers's MDT Position: Q2 2026 in Review
Nichols & Pratt Advisers reduced its Medtronic (MDT) stake by 9.8% in Q2 2026, selling an estimated $1.23M and leaving 141,131 shares worth $11M. The position accounts for 0.67% of the portfolio, ranked #32.
Nichols & Pratt Advisers first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.5M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Nichols & Pratt Advisers held 141,131 shares of Medtronic worth $11M as of Q2 2026.
- Nichols & Pratt Advisers sold 15,285 Medtronic shares in Q2 2026, an estimated $1.23M.
- Medtronic made up 0.67% of Nichols & Pratt Advisers's portfolio in Q2 2026, its #32 holding.
- Nichols & Pratt Advisers first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- Nichols & Pratt Advisers's Medtronic position peaked at $16.5M in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Nichols & Pratt Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.